FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.
FOXO Technologies Inc. (NYSE:FOXO) has announced its delisting from NYSE American due to its stock price falling below the $0.10 minimum requirement. Trading of FOXO's Class A common stock was suspended on NYSE on August 12, 2025.
The Company has successfully secured approval to trade on the Over-the-Counter (OTC) market starting August 13, 2025, maintaining its "FOXO" trading symbol. CEO Seamus Lagan emphasized that despite the delisting, the company's business strategy and economic outlook remain unchanged, with plans to pursue potential acquisitions for growth and consider future NYSE or NASDAQ listing when appropriate.
FOXO Technologies Inc. (NYSE:FOXO) ha annunciato la sua esclusione dalla NYSE American a causa del calo del prezzo delle azioni al di sotto del minimo richiesto di $0,10. La negoziazione delle azioni di Classe A di FOXO è stata sospesa sull'NYSE il 12 agosto 2025.
La Società ha ottenuto l'autorizzazione per negoziare sul mercato Over-the-Counter (OTC) a partire dal 13 agosto 2025, mantenendo il simbolo di negoziazione "FOXO". Il CEO Seamus Lagan ha sottolineato che, nonostante la cancellazione dalla quotazione, la strategia aziendale e le prospettive economiche restano invariate; la società intende valutare acquisizioni per favorire la crescita e prendere in considerazione una futura quotazione alla NYSE o al NASDAQ quando sarà opportuno.
FOXO Technologies Inc. (NYSE:FOXO) ha anunciado su exclusión de la NYSE American debido a que el precio de sus acciones cayó por debajo del requisito mínimo de $0.10. La negociación de las acciones Clase A de FOXO fue suspendida en la NYSE el 12 de agosto de 2025.
La Compañía obtuvo la aprobación para cotizar en el mercado Over-the-Counter (OTC) a partir del 13 de agosto de 2025, conservando el símbolo "FOXO". El CEO Seamus Lagan destacó que, a pesar de la exclusión, la estrategia comercial y las perspectivas económicas de la empresa no cambian; planean explorar adquisiciones para crecer y considerarán una futura cotización en NYSE o NASDAQ cuando sea apropiado.
FOXO Technologies Inc. (NYSE:FOXO)는 주가가 $0.10 최소 기준 아래로 떨어져 NYSE American에서의 상장폐지를 발표했습니다. FOXO의 클래스 A 보통주에 대한 거래는 2025년 8월 12일 NYSE에서 중단되었습니다.
회사는 2025년 8월 13일부터 장외시장(OTC)에서 거래할 수 있도록 승인받았으며, 거래 티커 "FOXO"는 유지됩니다. CEO 시어무스 라간(Seamus Lagan)은 상장폐지에도 불구하고 회사의 사업 전략과 재무 전망은 변함없으며, 성장을 위해 인수 기회를 모색하고 적절한 시점에 NYSE나 NASDAQ 재상장을 검토할 계획이라고 강조했습니다.
FOXO Technologies Inc. (NYSE:FOXO) a annoncé son retrait de la cotation de la NYSE American en raison d'une baisse du cours de son action sous le seuil minimum de 0,10 $. Les négociations sur les actions de classe A de FOXO ont été suspendues à la NYSE le 12 août 2025.
La société a obtenu l'autorisation de négocier sur le marché de gré à gré (OTC) à compter du 13 août 2025, en conservant le symbole "FOXO". Le PDG Seamus Lagan a souligné que, malgré ce retrait, la stratégie commerciale et les perspectives économiques restent inchangées : la société envisage d'explorer des acquisitions pour croître et d'envisager une nouvelle cotation à la NYSE ou au NASDAQ lorsque cela sera approprié.
FOXO Technologies Inc. (NYSE:FOXO) hat angekündigt, dass es von der NYSE American aufgrund eines Kursrückgangs unter die Mindestanforderung von $0,10 delistet wird. Der Handel mit FOXOs Stammaktien der Klasse A wurde am 12. August 2025 an der NYSE ausgesetzt.
Das Unternehmen hat die Genehmigung erhalten, ab dem 13. August 2025 am Over-the-Counter (OTC)-Markt zu handeln und behält dabei das Handelssymbol "FOXO". CEO Seamus Lagan betonte, dass trotz des Delistings die Geschäftsstrategie und die wirtschaftlichen Aussichten unverändert bleiben; geplant ist, mögliche Übernahmen zur Wachstumsförderung zu verfolgen und eine spätere Notierung an der NYSE oder NASDAQ zu prüfen, wenn dies angebracht ist.
- Successfully secured OTC market trading approval to maintain stock trading accessibility
- Company maintains SEC reporting compliance
- Management pursuing acquisitions to accelerate growth
- Delisted from NYSE American due to stock price falling below $0.10
- Stock trading suspension on NYSE indicates severe market value deterioration
- Loss of major exchange listing could reduce institutional investor interest and liquidity
WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (“FOXO” or the “Company”) announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to delist the Class A common stock of FOXO (Ticker symbol FOXO) from NYSE American, pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Class A commons stock. The share price went below the NYSE minimum price of
The Company submitted an application to have its common stock traded on the OTC and has on August 12, 2025 received confirmation from FINRA’s Department of Market Operations that the trading symbol, “FOXO” has been assigned by them to the Common Stock of Foxo Technologies, Inc., and that the Company’s Common Stock may be quoted and traded on the OTC market as of August 13, 2025.
“While we are disappointed that our share price has fallen below the
About FOXO Technologies Inc. (“FOXO”)
FOXO owns and operates three subsidiaries.
Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access designated (CAH) hospital in East Tennessee.
Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.
FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.
For more information about FOXO, visit www.foxotechnologies.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151
FAQ
Why was FOXO Technologies (FOXO) delisted from NYSE American?
Where will FOXO Technologies stock trade after NYSE delisting?
What is FOXO Technologies' plan after being delisted from NYSE?
How does the NYSE delisting affect FOXO Technologies shareholders?
When was FOXO Technologies' last day of trading on NYSE American?
